600223.SH
福瑞达
SSE · Healthcare · Real Estate - Development · CN
CNY 5.55
+1.28%Year over year
Reported trailing growth
- Revenue
- -7.4%
- EBITDA
- —
- EBIT
- -21.3%
- EPS
- -29.3%
- Free cash flow
- +464.2%
- Operating cash flow
- +396.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -34.4%
- EBITDA
- -2.5%
- EBIT
- -2.7%
- Net income
- +60.4%
- EPS
- +65.1%
- Free cash flow
- -41.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026